Esomeprazole Magnesium Capsule, Coated Pellets
Product Images NDC 76420-226

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 76420-226). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole-20mg (Esomeprazole 20mg)

Packaging labels for Esomeprazole magnesium delayed release capsules 20 mg from Enovachem Pharmaceuticals, relabeled by Enovachem and distributed by Ascend Laboratories, LLC. Labels display NDC codes for 30, 60, and 90-count bottles, along with storage instructions, batch number placeholders, and caution statements about prescription dispensing.*

FDA Label Image

Esomeprazole-40mg (Esomeprazole 40mg)

Packaging labels for Esomeprazole Magnesium delayed release capsules, USP 40 mg, coated pellets oral capsules. Labels show NDC numbers 76420-227-30, 76420-227-60, and 76420-227-90 with quantities of 30, 60, and 90 capsules respectively. Labeler is Enovachem Pharmaceuticals, with distributor Ascend Laboratories, LLC. Labels include storage instructions and legal cautions.*

FDA Label Image

Esomeprazole-fig-2 (Esomeprazole Fig 2)

A line graph depicting the percent of participants maintaining a condition over a six-month period for Esomeprazole magnesium delayed release capsules at 10 mg, 20 mg, and 40 mg doses, compared to placebo. The graph shows higher maintenance percentages with increasing Esomeprazole doses over time.*

FDA Label Image

Esomeprazole-fig-3 (Esomeprazole Fig 3)

A line graph depicting percent maintained over a 6-month period for four groups: Esomeprazole 40 mg, Esomeprazole 20 mg, Esomeprazole 10 mg, and a placebo group. The vertical axis shows percent maintained, while the horizontal axis represents time in months. Each group is represented by a distinct line with markers, showing trends in percent maintained by month.*

FDA Label Image

Esomeprazole-fig-4 (Esomeprazole Fig 4)

A line graph depicting the percent of patients symptom-free over 28 days. It compares three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo, with daily measurements on the x-axis and percent symptom-free on the y-axis.*

FDA Label Image

Esomeprazole-fig-5 (Esomeprazole Fig 5)

A line graph showing percent of patients symptom-free over 28 days, comparing Esomeprazole magnesium delayed release capsules at 20 mg and 40 mg doses and placebo. The x-axis is labeled as Diary Day (from 0 to 28), and the y-axis as Percent of Patients Symptom-Free (0 to 100%).*

FDA Label Image

Esomeprazole-structure (Esomeprazole Structure)

Chemical structure of esomeprazole magnesium, showing the molecular arrangement including magnesium ion complexed with two esomeprazole molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.